Exoskeleton-assisted Upper Limb Rehabilitation After Stroke

Overview

In recent studies, it has been observed that robotic devices make a positive contribution to motor recovery and the activities of daily living. However, studies about the effects of stroke rehabilitation with robotic devices are limited. This study aimed to investigate the effect of upper extremity robotic rehabilitation on motor function and quality of life in stroke patients.

Full Title of Study: “Exoskeleton-assisted Upper Limb Rehabilitation After Stroke: A Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Triple (Participant, Care Provider, Outcomes Assessor)
  • Study Primary Completion Date: May 15, 2019

Detailed Description

Stroke survivors have difficulties in participating in activities of daily living due to functional disabilities. The majority of patients after stroke need rehabilitation to gain independence in daily life as the first target. Therefore, different treatment approaches are used in stroke rehabilitation. The use of technology in stroke rehabilitation has become very common in recent years. Robotic devices used in rehabilitation enhance the healing process by giving patients more intensive and task-oriented exercises. A lot of systematic and meta-analysis studies have shown that robot-assisted devices provide positive motor recoveries, especially in the treatment of upper extremities. However, the optimal timing, duration, and dose of robotic rehabilitation that should be applied after stroke remain uncertain. In the light of this information, this study examines the effects of the robotic device produced for upper limb rehabilitation on daily life activities and motor function.

Interventions

  • Device: Exoskeleton robot for upper extremity
    • Robot-assisted Treatment Program: 10 minutes elbow flexion/extension 10 minutes forearm supination/pronation 10 minutes wrist flexion/extension 10 minutes ulnar/radial deviation Frequency: 2/week Duration: 12 sessions (6 weeks)
  • Other: Conventional physiotherapy
    • Ferquency: 2/week Duration: 12 sessions (6weeks) Each session: 50 minutes

Arms, Groups and Cohorts

  • Active Comparator: Robot-assisted Treatment
    • Rehabilitation protocol was applied with robotic device (HOUSTONBIONİCS ExoRehab UE1).
  • Active Comparator: Conventional Physiotherapy
    • Conventional physiotherapy program included neurophysiological approaches.

Clinical Trial Outcome Measures

Primary Measures

  • Fugl-Meyer Upper Extremity Assessment
    • Time Frame: before treatment and at six weeks of the beginning of the treatment
    • Fugl-Meyer Upper Extremity Assessment is an index to assess physical performance in individuals who had a stroke. This index consists of 33 items. Each item scored between 0 and 2. The highest score for the upper extremity is 66.
  • Modified Ashworth Scale
    • Time Frame: before treatment and at six weeks of the beginning of the treatment
    • Modified Ashworth Scale is used for measuring the spasticity of upper extremity skeletal muscle. The Modified Ashworth Scale (MAS) is scored from 0 to 5 to measure the resistance encountered when performing passive muscle stretching. The lowest score is 0 (no spasticity) and the highest score is 5 (severe spasticity).

Secondary Measures

  • Upper Extremity Motor Activity Log
    • Time Frame: before treatment and at six weeks of the beginning of the treatment
    • Upper Extremity Motor Activity Log consists of two subscales (amount of use and quality of movement) that determine how often the patient uses the affected side in daily life activities and how successful this activity is. Items on each scale are scored between 0 and 5.
  • Nottingham Extended Activities of Daily Living Scale
    • Time Frame: before treatment and at six weeks of the beginning of the treatment
    • Nottingham Extended Activities of Daily Living Scale is designed for stroke patients but can be also used for other diseases. The scale has 22 items divided into 4 areas of daily life. These areas are mobility, kitchen, domestic and leisure activities. Each item scored between 0 and 3. The highest score of scale is 66.

Participating in This Clinical Trial

Inclusion Criteria

  • Having ischemic or hemorrhagic stroke history – Being at the age between 40 and 85 – MAS (Modified Ashworth Scale) < 3 for upper extremity – At least 6 months after stroke – Participants who agree to participate in the study Exclusion Criteria:

  • Cardiovascular weakness (severe hypertension, coronary artery disease) – Mini-Mental State Examination score < 24 – Recurrent stroke – Having other orthopedic and neurologic conditions that may affect upper extremity movement – Having behavioral and cognitive problems

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: 85 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Marmara University
  • Provider of Information About this Clinical Study
    • Principal Investigator: iremakgun, Physiotherapist – Marmara University
  • Overall Official(s)
    • İrem Akgün, Principal Investigator, Marmara University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.